Breaking News Instant updates and real-time market news.

2020-12-01 07:28:17 LNC Lincoln National $47.23 / -1.92 (-3.91%) 07:28 12/01/20 12/01 07:28 12/01/20 07:28	Credit Suisse upgrades Lincoln National to Outperform with $56 target Credit Suisse analyst Andrew Kligerman upgraded Lincoln National to Outperform from Neutral with a price target of $56, up from $41. Post-COVID-19 impacts, the company should see high-single digit annual earnings growth, Kligerman tells investors in a research note. The analyst also expects potential accretion from annuity block divestitures and "solid" capitalization and risk management. These factors are "compelling," particularly in light of Lincoln's current valuation, says Kligerman.
LNC Lincoln National $47.23 / -1.92 (-3.91%) 12/01/20 Credit Suisse Lincoln National upgraded to Outperform from Neutral at Credit Suisse 11/17/20 Barclays Lincoln National initiated with an Equal Weight at Barclays 10/23/20 Citi Citi opens '30-day positive catalyst watch' on Lincoln National 07/16/20 Credit Suisse Lincoln National price target lowered to $41 from $52 at Credit Suisse

2020-12-01 07:28:17

LNC

Lincoln National

$47.23 / -1.92 (-3.91%)

07:28

12/01/20

12/01

07:28

12/01/20

07:28

Credit Suisse upgrades Lincoln National to Outperform with $56 target

Credit Suisse analyst Andrew Kligerman upgraded Lincoln National to Outperform from Neutral with a price target of $56, up from $41. Post-COVID-19 impacts, the company should see high-single digit annual earnings growth, Kligerman tells investors in a research note. The analyst also expects potential accretion from annuity block divestitures and "solid" capitalization and risk management. These factors are "compelling," particularly in light of Lincoln's current valuation, says Kligerman.

LNC Lincoln National

$47.23 / -1.92 (-3.91%)

12/01/20 Credit Suisse: Lincoln National upgraded to Outperform from Neutral at Credit Suisse

11/17/20 Barclays: Lincoln National initiated with an Equal Weight at Barclays

10/23/20 Citi: Citi opens '30-day positive catalyst watch' on Lincoln National

07/16/20 Credit Suisse: Lincoln National price target lowered to $41 from $52 at Credit Suisse

TODAY'S FREE FLY STORIES

Recommendations	GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09:56 Today Fly Intel: Top five analyst downgrades 06:32 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 05:29 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/15/21 Deutsche Bank GlaxoSmithKline initiated with a Hold at Deutsche Bank GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/08/20 Moderna slides as analyst says sell on rising COVID vaccine competition 03/03/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st
Hot Stocks	First Eagle Alternative Credit COO, CFO Terry Olson to retire » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) First Eagle Alternative… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan
Recommendations	Ferguson price target raised to 10,050 GBp from 9,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 FERGY Ferguson $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FERGY Ferguson $0.00 / + (+0.00%) 01/14/21 Berenberg Ferguson downgraded to Sell from Hold at Berenberg 01/05/21 UBS Ferguson U.K. sale not that material, says UBS 01/05/21 RBC Capital Ferguson forecasts adjusted at RBC Capital 12/09/20 Barclays Ferguson price target raised to 9,000 GBp from 8,000 GBp at Barclays
Recommendations	CRH price target raised to 3,600 GBp from 3,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 CRH CRH $44.88 / -0.12 (-0.27%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRH CRH $44.88 / -0.12 (-0.27%) 09/21/20 Ash Grove to upgrade import terminal in Florida CRH CRH $44.88 / -0.12 (-0.27%) 01/14/21 Berenberg CRH initiated with a Hold at Berenberg 01/08/21 JPMorgan CRH price target raised to EUR 41 from EUR 40 at JPMorgan 01/06/21 Societe Generale CRH upgraded to Buy on apparent Democratic majority at Societe Generale 01/06/21 Societe Generale CRH upgraded to Buy from Hold at Societe Generale CRH CRH $44.88 / -0.12 (-0.27%) 12/23/20 HeidelbergCement working to sell California operations, Bloomberg reports
Recommendations	Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BKIMF Bankinter $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays 10/23/20 UBS Bankinter price target lowered to EUR 3.45 from EUR 3.55 at UBS

Recommendations	Bankia price target raised to EUR 1.52 from EUR 1.09 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BNKXF Bankia $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals BNKXF Bankia $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares BNKXF Bankia $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankia price target raised to EUR 1.20 from EUR 1.10 at JPMorgan 11/25/20 HSBC Bankia downgraded to Hold from Buy at HSBC 10/29/20 UBS Bankia price target lowered to EUR 1.09 from EUR 1.15 at UBS 10/20/20 UBS Bankia price target lowered to EUR 1.15 from EUR 1.30 at UBS BNKXF Bankia $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports 09/03/20 Bankia, Caixabank say they are considering merger, Bloomberg says
Periodicals	Tesla lowers Model 3 prices in Europe, Electrek reports » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 TSLA Tesla $844.31 / -0.26 (-0.03%) Tesla has reduced Model 3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 EU passenger car registrations down 3.3% in December 01/14/21 Tesla director sells 10K shares of common stock 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Tesla Model Y achieves 5-Star overall safety rating from NHTSA TSLA Tesla $844.31 / -0.26 (-0.03%) 09:16 Today JPMorgan JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous 07:39 Today Deutsche Bank Tesla price target raised to $890 from $705 at Deutsche Bank 06:48 Today Oppenheimer Tesla price target raised to $1,036 from $486 at Oppenheimer 01/19/21 Jefferies Tesla price target raised to $775 from $650 at Jefferies TSLA Tesla $844.31 / -0.26 (-0.03%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close 14 Feb TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/19/21 Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports 01/18/21 Tesla says Model Y deliveries in China have officially begun 01/13/21 NHTSA asks Tesla to recall 158,000 cars over faulty touchscreens, Reuters says TSLA Tesla $844.31 / -0.26 (-0.03%) 01/14/21 Fly Intel: Pre-market Movers 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla 01/08/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers 01/27/21 Tesla - TSLA TSLA Tesla $844.31 / -0.26 (-0.03%) 08:55 Today Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th 01/11/21 Notable open interest changes for January 11th
Recommendations	Banco de Sabadell price target raised to EUR 0.40 from EUR 0.27 at UBS » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 BNDSF Banco de Sabadell $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals BNDSF Banco de Sabadell $0.00 / + (+0.00%) 11/27/20 Keefe Bruyette Sabadell downgraded to Underperform from Market Perform at Keefe Bruyette 11/05/20 UBS Banco de Sabadell price target lowered to EUR 0.27 from EUR 0.28 at UBS 11/03/20 Deutsche Bank Banco de Sabadell price target raised to EUR 0.45 at Deutsche Bank 10/20/20 UBS Banco de Sabadell price target lowered to EUR 0.28 from EUR 0.30 at UBS BNDSF Banco de Sabadell $0.00 / + (+0.00%) 09/08/20 Sabadell exploring strategic options, Bloomberg reports
Recommendations	Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse » 11:33 01/20/21 01/20 11:33 01/20/21 11:33 BAYRY Bayer $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Bayer says FDA approves addition of OS and other data to Nubeqa prescribing info 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine 12/22/20 Bayer, Veracyte announce new collaboration to advance precision oncology BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 67 at Morgan Stanley 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/07/20 Stifel Atara Biotherapeutics price target raised to $33 from $28 at Stifel 12/07/20 Roth Capital Bayer collaboration a testament to Atara's T-cell prowess, says Roth Capital BAYRY Bayer $0.00 / + (+0.00%) 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09/30/20 Bayer confirms 2020 adjusted view, sees 2021 core EPS 'slightly' down from 2020 09/30/20 Bayer expects 2021 sales at approximately 2020 levels BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 00:00 Today PDUFA Date for Vericiguat
Recommendations	Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 GRFS Grifols $19.38 / -0.4 (-2.02%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GRFS Grifols $19.38 / -0.4 (-2.02%) 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M 10/09/20 Grifols begins anti-SARS-CoV-2 hyperimmune globulin trial GRFS Grifols $19.38 / -0.4 (-2.02%) 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley 12/09/20 Morgan Stanley Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley 11/06/20 Morgan Stanley Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley 10/30/20 Berenberg Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg GRFS Grifols $19.38 / -0.4 (-2.02%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports GRFS Grifols $19.38 / -0.4 (-2.02%) 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers

Recommendations	Orion Oyj price target raised to EUR 35 from EUR 30 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 ORINF Orion Oyj $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Ahold Delhaize price target lowered to EUR 24 from EUR 25 at Credit Suisse » 11:30 01/20/21 01/20 11:30 01/20/21 11:30 ADRNY Ahold Delhaize $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/18/20 Ahold Delhaize, Centerbridge Partners to buy FreshDirect, terms not disclosed ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/20/20 Stifel Ahold Delhaize upgraded to Hold from Sell at Stifel 11/10/20 Morgan Stanley Ahold Delhaize price target raised to EUR 25.40 from EUR 25 at Morgan Stanley 11/09/20 Credit Suisse Ahold Delhaize initiated with a Neutral at Credit Suisse 11/05/20 JPMorgan Ahold Delhaize price target lowered to EUR 22 from EUR 23 at JPMorgan
Recommendations	easyJet price target raised to 934 GBp from 840 GBp at Credit Suisse » 11:29 01/20/21 01/20 11:29 01/20/21 11:29 ESYJY easyJet $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ESYJY easyJet $0.00 / + (+0.00%) 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi easyJet downgraded to Sell from Neutral at Citi 12/17/20 Morgan Stanley easyJet price target raised to 900 GBp from 800 GBp at Morgan Stanley 12/14/20 AlphaValue easyJet upgraded to Reduce from Sell at AlphaValue ESYJY easyJet $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports
Recommendations	KBC Group price target lowered to EUR 60 from EUR 61 at Deutsche Bank » 11:27 01/20/21 01/20 11:27 01/20/21 11:27 KBCSY KBC Group $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KBCSY KBC Group $0.00 / + (+0.00%) 01/14/21 Morgan Stanley KBC Group price target raised to EUR 71 from EUR 67 at Morgan Stanley 01/11/21 Deutsche Bank KBC Group downgraded to Hold from Buy at Deutsche Bank 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank » 11:26 01/20/21 01/20 11:26 01/20/21 11:26 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS 07/17/20 Berenberg Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg 07/16/20 Deutsche Bank Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank

Recommendations	AirBoss of America price target lowered to C$28 from C$31 at CIBC » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 ABSSF AirBoss of America $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities 11/12/20 Stifel AirBoss of America price target lowered to C$33 from C$34 at Stifel 11/12/20 TD Securities AirBoss of America price target raised to C$32 from C$31 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M
Options	Vertical call spread in energy ETF targets 26% return for 2021 » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) Vertical call spread in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options Technical Analysis XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 12/29/20 Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21 08/05/20 Energy shares surge amid spike in natural gas, crude inventory drop XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 07/06/20 Goldman Sachs Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 01/08/21 Size call sale in Energy ETF likely closes December trade 12/14/20 Unusually active option classes on open December 14th XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 08:25 Today Energy Select Sector SPDR: Pivot points 01/15/21 On The Fly: Weekly technical notes for S&P 500 01/15/21 Energy Select Sector SPDR: Pivot points 01/14/21 Energy Select Sector SPDR: Pivot points
Periodicals	Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 BAM Brookfield $38.51 / +0.18 (+0.47%) , KKR KKR $41.52 / +0.55 (+1.34%) , APO Apollo Global $48.08 / -0.1 (-0.21%) Brookfield Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/04/21 Brookfield Property establishes committee to review Brookfield proposal 01/04/21 Brookfield proposes to acquire remaining Brookfield Property units for $5.9B 12/30/20 JCPenney replacing CEO Jill Soltau, Stanley Shashoua stepping in for now 12/14/20 Blackstone unit BPPLS to acquire portfolio of lab properties for $3.45B KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes first Asia real estate Fund at $1.7B 01/13/21 Fiserv, KKR called out as best ideas by Oakmark's Bill Nygren 01/12/21 KKR expands real estate industrial portfolio in Phoenix 01/11/21 KKR invests in music catalog of Ryan Tedder and OneRepublic APO Apollo Global $48.08 / -0.1 (-0.21%) 01/04/21 Takkion Holdings acquires Renew Energy; terms not disclosed 12/23/20 Apollo-led group to acquire 49.9% stake in AB InBev U.S. metal container plants 12/21/20 Apollo agrees to increase Great Canadian Gaming purchase price to C$45 per share 12/15/20 Cardtronics transaction indicates enterprise value of $2.3B, including net debt BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/05/21 JPMorgan Brookfield deal 'value accretive and multiple enhancing,' says JPMorgan 12/23/20 RBC Capital Brookfield assumed with an Outperform at RBC Capital 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 Goldman Sachs Brookfield initiated with a Conviction Buy at Goldman Sachs KKR KKR $41.52 / +0.55 (+1.34%) 01/11/21 Citi Citi opens 'positive Catalyst Watches' on Invesco, Carlyle, KKR 11/11/20 Deutsche Bank KKR price target raised to $40 from $38 at Deutsche Bank 08/05/20 Citi Citi adds KKR to U.S. Focus List, ups price target to $47.50 07/09/20 Keefe Bruyette KKR price target raised to $41 from $34 at Keefe Bruyette APO Apollo Global $48.08 / -0.1 (-0.21%) 09:15 Today Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank 11/06/20 Fly Intel: Top five analyst upgrades BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/12/20 Brookfield reports Q3 EPS 10c, consensus 47c 08/13/20 Brookfield reports Q2 EPS (43c), consensus 39c KKR KKR $41.52 / +0.55 (+1.34%) 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 08/04/20 KKR reports Q2 adjusted EPS 39c, consensus 36c 08/03/20 Notable companies reporting before tomorrow's open 08/03/20 Notable companies reporting before tomorrow's open APO Apollo Global $48.08 / -0.1 (-0.21%) 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Apollo Global reports Q2 fee-related EPS 59c, consensus 48c 11 Nov BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/10/20 Brookfield seeks to enter secondary market for private assets, Bloomberg says 10/25/20 Blackstone to buy Simply Self storage for $1.2B, WSJ reports 10/22/20 JCPenney's new owners reject pension plan, Dallas Morning News reports 10/19/20 Brookfield investing $2B in biggest Indian property deal yet, Bloomberg says KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes inaugural APAC real estate fund at $1.7B, Reuters says 11/19/20 Bain, KKR weigh offers for Hitachi Metals, Nikkei Asia reports 11/18/20 Epic, Spotify not impressed with Apple App Store policy update, CNBC says 11/05/20 'Fortnite' to be playable on iOS devices via Nvidia GeForce, BBC reports APO Apollo Global $48.08 / -0.1 (-0.21%) 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says APO APO Apollo Global $48.08 / -0.1 (-0.21%) 09/25/20 Sports betting space gains after William Hill receives two takeover offers 09/25/20 Fly Intel: Pre-market Movers 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns 09/03/20 Tesla slides as investor trims stake, QuantumScape joins EV SPAC craze 02/24/21 22nd Annual Virtual Financial Services Forum 02/03/21 Apollo Global - APO 02/11/21 Brookfield - BAM APO APO Apollo Global $48.08 / -0.1 (-0.21%) 10/22/20 Apollo Global put volume heavy and directionally bearish
Syndicate	Oyster Enterprises Acquisition opens at $10.17, IPO priced at $10 per unit » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 OSTR Oyster Enterprises Acquisition $0.00 / + (+0.00%) Oyster Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 11:17 01/20/21 01/20 11:17 01/20/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary

Recommendations	Travis Perkins price target raised to 1,450 GBp from 1,360 GBp at Canaccord » 11:15 01/20/21 01/20 11:15 01/20/21 11:15 TVPKF Travis Perkins $0.00 / + (+0.00%) Canaccord analyst Aynsley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TVPKF Travis Perkins $0.00 / + (+0.00%) 01/08/21 JPMorgan Travis Perkins upgraded to Neutral from Underweight at JPMorgan 12/18/20 RBC Capital Travis Perkins price target raised to 1,300 GBp from 1,250 GBp at RBC Capital 04/08/20 JPMorgan Travis Perkins downgraded to Underweight from Neutral at JPMorgan
General news	FX Action: USD-CAD » 11:15 01/20/21 01/20 11:15 01/20/21 11:15 FX Action: USD-CAD… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Vermilion Energy price target raised to C$8 from C$7 at RBC Capital » 11:11 01/20/21 01/20 11:11 01/20/21 11:11 VET Vermilion Energy $5.80 / +0.28 (+5.07%) RBC Capital analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/17/20 Vermilion Energy announces changes to its leadership team 09/24/20 Vermilion Energy provides update on Total's Grandpuits refinery conversion VET Vermilion Energy $5.80 / +0.28 (+5.07%) 01/19/21 National Bank Vermilion Energy price target lowered to C$6.50 from C$7 at National Bank 01/19/21 TD Securities Vermilion Energy price target lowered to C$6.50 from C$7 at TD Securities 01/15/21 Raymond James Vermilion Energy upgraded to Outperform from Market Perform at Raymond James 01/14/21 Scotiabank Vermilion Energy price target raised to C$8.50 from C$8 at Scotiabank VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/09/20 Vermilion Energy reports Q3 FFO 73c vs. $1.39 last year 07/27/20 Vermilion Energy reports Q2 FFO 52c vs. $1.09 last year
Options	Bull tries on $2M worth of Under Armour March 20 calls » 11:10 01/20/21 01/20 11:10 01/20/21 11:10 UAA Under Armour $18.45 / +0.325 (+1.79%) Bull tries on $2M worth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options UAA Under Armour $18.45 / +0.325 (+1.79%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal UAA Under Armour $18.45 / +0.325 (+1.79%) 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities 01/07/21 JPMorgan Under Armour price target raised to $19 from $17 at JPMorgan 01/04/21 Pivotal Research Under Armour upgraded to Buy from Hold at Pivotal Research 12/09/20 UBS Under Armour price target raised to $17 from $10 at UBS UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open UAA Under Armour $18.45 / +0.325 (+1.79%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 07/31/20 Fly Intel: Pre-market Movers 07/27/20 Fly Intel: Pre-market Movers UAA Under Armour $18.45 / +0.325 (+1.79%) 12/08/20 Unusual call flow in option market yesterday 12/07/20 Upside call buyer in Under Armour closing position 12/07/20 Unusually active option classes on open December 7th 10/30/20 Unusually active option classes on open October 30th
Recommendations	Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital » 11:09 01/20/21 01/20 11:09 01/20/21 11:09 CSFFF Capstone Mining $0.00 / + (+0.00%) BMO Capital analyst Rene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 11:00 Today TD Securities Capstone Mining price target raised to C$3.50 from C$3 at TD Securities 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Credit Suisse upgrades Lincoln National to Outperform with $56 target

TODAY'S FREE FLY STORIES

Get Full Fly Access